Back to Journals » Journal of Blood Medicine » Volume 6

A case of Hodgkin’s lymphoma with severely impaired liver function treated successfully with gemcitabine followed by ABVD

Authors Chakraborty R, Mukkamalla SKR, Gutzmore G, Chan HC

Received 13 May 2014

Accepted for publication 9 June 2014

Published 23 March 2015 Volume 2015:6 Pages 93—97


Checked for plagiarism Yes

Review by Single-blind

Peer reviewer comments 3

Rajshekhar Chakraborty,1 Shiva Kumar Reddy Mukkamalla,2 Garfield Gutzmore,2 Hon Cheung Chan,2

1Hospitalist Services, Essentia Health, Brainerd, MN, USA; 2Department of Internal Medicine, Queens Hospital Center (Affiliated Icahn School of Medicine at Mount Sinai), Jamaica, NY, USA

Abstract: Hodgkin’s lymphoma (HL) originates from clonal B cells and is the most common malignancy in the second decade of life. Liver involvement is uncommon at presentation in patients with HL and there is a paucity of data for treatment of patients with severely impaired liver function. We present an unusual case of HL with severe hepatic impairment, splenomegaly and multiple chromosomal abnormalities that was treated initially with gemcitabine and steroids. Once liver function tests improved, six cycles of Adriamycin, bleomycin, vinblastine, and dacarbazine were administered. The patient remains in remission at 3.5 years of follow-up.

Keywords: hepatomegaly, cytogenetics, remission

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]